PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
11975681-7	2002	ALRT 1550 (5 microM) in combination with IFN-gamma at a concentration of 500 U/ml inhibited cell growth of SKOV-3 by as much as 81% (CI = 1.88).	skov-3	107-113	interferon gamma	Homo sapiens	41-50
17070899-8	2007	By contrast, an increase in Akt activity reduces PAI-1 expression and results in an increase in SKOV-3 wound-induced cell migration.	skov-3	96-102	AKT serine/threonine kinase 1	Homo sapiens	28-31
2322985-7	1990	Pretreatment of the cell line with TNF for 3 h and subsequent washing resulted in significant cytotoxicity of the sensitive PA-1 line and some cytotoxicity against SKOV-3.	skov-3	164-170	tumor necrosis factor	Homo sapiens	35-38
27784677-8	2016	SU11274 attenuated the effects of HGF on Rb, h, and micromotion in the SKOV-3 monolayer.	skov-3	71-77	hepatocyte growth factor	Homo sapiens	34-37
29103028-9	2017	PD98059, a MEK inhibitor, suppresses the ERK pathway and the EMT process of SKOV-3/DDP.	skov-3	76-82	mitogen-activated protein kinase kinase 7	Homo sapiens	11-14
24785108-4	2014	There was 96% (P < 0.001) increased cell motility in Wnt5a-transfected SKOV-3 (SKOV-3/Wnt5a) cells compared to SKOV-3, which was abrogated in the presence of JNK inhibitor.	skov-3	74-80	Wnt family member 5A	Homo sapiens	56-61
27904527-11	2016	Activatory effects of IL-2 and inhibitory effects of IL-10 in co-culture of SKOV-3 and PBMCs were observed.	skov-3	76-82	interleukin 10	Homo sapiens	53-58
26722376-8	2016	Pre-saturation of SKOV-3 with non-labeled anti-HER2 Affibody or the use of HER2-negative Ramos xenografts resulted in significantly lower tumor uptake of (111)In-ZHER2:342-SR-HP1.	skov-3	18-24	erb-b2 receptor tyrosine kinase 2	Homo sapiens	47-51
26722376-8	2016	Pre-saturation of SKOV-3 with non-labeled anti-HER2 Affibody or the use of HER2-negative Ramos xenografts resulted in significantly lower tumor uptake of (111)In-ZHER2:342-SR-HP1.	skov-3	18-24	chromobox 5	Homo sapiens	175-178
25374174-9	2014	In addition, SKOV-3.ip1 cells also overexpressed miR-200a compared with SKOV-3, and miR-200a inhibitor transfected SKOV-3.ip1 cells showed significant reduction in cellular proliferation and invasion, while a miR-200a mimic stimulated the opposite behavior.	skov-3	13-19	microRNA 200a	Homo sapiens	49-57
25374174-9	2014	In addition, SKOV-3.ip1 cells also overexpressed miR-200a compared with SKOV-3, and miR-200a inhibitor transfected SKOV-3.ip1 cells showed significant reduction in cellular proliferation and invasion, while a miR-200a mimic stimulated the opposite behavior.	skov-3	13-19	microRNA 200a	Homo sapiens	84-92
25374174-9	2014	In addition, SKOV-3.ip1 cells also overexpressed miR-200a compared with SKOV-3, and miR-200a inhibitor transfected SKOV-3.ip1 cells showed significant reduction in cellular proliferation and invasion, while a miR-200a mimic stimulated the opposite behavior.	skov-3	13-19	microRNA 200a	Homo sapiens	84-92
26951567-7	2016	RESULTS: NCL-240 micelles and the combination NCL-240/TRAIL micelles significantly increased cytotoxicity in the resistant strains of SKOV-3, MCF-7 and A549 as compared to free drugs or single drug formulations.	skov-3	134-140	nucleolin	Homo sapiens	9-12
26951567-7	2016	RESULTS: NCL-240 micelles and the combination NCL-240/TRAIL micelles significantly increased cytotoxicity in the resistant strains of SKOV-3, MCF-7 and A549 as compared to free drugs or single drug formulations.	skov-3	134-140	nucleolin	Homo sapiens	46-49
26951567-7	2016	RESULTS: NCL-240 micelles and the combination NCL-240/TRAIL micelles significantly increased cytotoxicity in the resistant strains of SKOV-3, MCF-7 and A549 as compared to free drugs or single drug formulations.	skov-3	134-140	TNF superfamily member 10	Homo sapiens	54-59
24785108-4	2014	There was 96% (P < 0.001) increased cell motility in Wnt5a-transfected SKOV-3 (SKOV-3/Wnt5a) cells compared to SKOV-3, which was abrogated in the presence of JNK inhibitor.	skov-3	74-80	Wnt family member 5A	Homo sapiens	82-94
24785108-4	2014	There was 96% (P < 0.001) increased cell motility in Wnt5a-transfected SKOV-3 (SKOV-3/Wnt5a) cells compared to SKOV-3, which was abrogated in the presence of JNK inhibitor.	skov-3	74-80	mitogen-activated protein kinase 8	Homo sapiens	161-164
24785108-4	2014	There was 96% (P < 0.001) increased cell motility in Wnt5a-transfected SKOV-3 (SKOV-3/Wnt5a) cells compared to SKOV-3, which was abrogated in the presence of JNK inhibitor.	skov-3	82-88	Wnt family member 5A	Homo sapiens	56-61
24785108-4	2014	There was 96% (P < 0.001) increased cell motility in Wnt5a-transfected SKOV-3 (SKOV-3/Wnt5a) cells compared to SKOV-3, which was abrogated in the presence of JNK inhibitor.	skov-3	82-88	mitogen-activated protein kinase 8	Homo sapiens	161-164
22207928-9	2011	The half maximal inhibitory concentration (IC50) of SKOV-3/DCC cells was significantly lower than that of SKOV-3 or SKOV-3/Neo cells (all P<0.05).	skov-3	52-58	DCC netrin 1 receptor	Homo sapiens	59-62